Er zijn momenteel geen informatiefolders beschikbaar.
{"title":"Informatiefolders","categories":"Kankercentrum|c0454f63-cdaf-4f86-a557-d7619410fd80;Algemeen|8b513162-7437-46c1-82cb-3c22b0a6af09;Digestieve oncologie|dd7f5b3d-984b-4715-8163-dd8faa198abe;Melanomen en huidtumoren|c0e39cb5-082d-4425-9e5b-71fc85cf27ef;Thoracale oncologie|24b918ae-7213-46f7-aa7b-44361856c81f;Urologische oncologie|12b1be87-7ab6-44f7-aa34-bfe0602644fb;Borstkanker|94c8d0ee-7308-43d3-8879-5dd35db30e14;Chemotherapie|af2cdcf7-cd71-46cd-8833-2d0720671e40;Hoofd- en halstumoren|c342e5d3-d6b8-4900-ae88-9f809d91495e;Huidkanker|463d1a2d-aac5-4b21-8a51-6a809b876604;Ondersteuning, welzijn en revalidatie|e61d0ace-2c6b-4164-bf17-2cdb8b90be38;Preventie|77607faa-25d2-4235-a10e-048251731173;Voeding|1cdc7674-f401-4eb8-82c5-1d4fe2c16c64;Vruchtbaarheid|6da1fd83-1173-4ae7-b6bf-75296bce6a82;Hemato-oncologie en stamceltransplantatie|0e2533ed-7b24-47ed-822d-1f69312717e0;Neuro-oncologie|c4a8259c-c3a8-437c-97f8-fe6c6456f871;Pelviene oncologie|f00ba738-ae94-409e-9d0e-5143a789bf26;Sarcomen en bottumoren|84b9b0ff-39ed-4081-8c5a-2254949542d2;Gynaecologische oncologie|7a727b79-86cb-4bcc-836c-b56cc005ed6a","categoriesInfosheet":[{"id":"c0454f63-cdaf-4f86-a557-d7619410fd80","name":"Kankercentrum","categories":[{"id":"8b513162-7437-46c1-82cb-3c22b0a6af09","name":"Algemeen","categories":[],"infosheets":[{"title":"CoZo: betere zorg door uitwisseling van uw medische gegevens","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/zorgmap-cozo.pdf"},{"title":"Decitabine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/decitabine.pdf"},{"title":"Droge mond als gevolg van een kankerbehandeling","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/droge-mond-bij-kankerbehandeling.pdf"},{"title":"Fotosensitiviteit en zonnebescherming","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Fotosensitiviteit-zonneprotectie-chemotherapie.pdf"},{"title":"Gespreksgids","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Gespreksgids-oncologie.pdf"},{"title":"Haarverlies en hoofdhuidkoeling","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Hoofdhuidkoeling.pdf"},{"title":"Immunotherapie bij kanker","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/immunotherapie-kanker.pdf"},{"title":"Jong en kanker","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/boekje-jong-en-kanker.pdf"},{"title":"Lasertherapie voor de behandeling van orale mucositis","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Lasertherapie-behandeling-orale-mucositis.pdf"},{"title":"Met (klein)kinderen praten over ziek zijn/kanker","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/kinderen-praten-kanker.pdf"},{"title":"Omgaan met de diagnose en de behandeling","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Omgaan-met-diagnose-behandeling.pdf"},{"title":"Regelgeving gebruik infraroodcabine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/regelgeving-gebruik-infraroodcabine.pdf"},{"title":"Verpleegkundig spreekuur dagkliniek Medische oncologie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/verpleegkundig spreekuur-dagkliniek Medische oncologie.pdf"},{"title":"Vidaza","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/vidaza.pdf"},{"title":"Waarvoor kan ik terecht bij de ziekenhuisapotheker","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Ziekenhuisapotheker.pdf"},{"title":"Wat is kanker?","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Wat-is-kanker.pdf"},{"title":"Wellness en massage voor mensen met kanker","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/wellness-massage-kanker.pdf"},{"title":"Xgeva","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Xgeva.pdf"},{"title":"Zometa (zoledroninezuur)","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Behandeling-Zometa.pdf"}],"count":19,"parent":"c0454f63-cdaf-4f86-a557-d7619410fd80"},{"id":"94c8d0ee-7308-43d3-8879-5dd35db30e14","name":"Borstkanker","categories":[],"infosheets":[{"title":"Abemaciclib (Verzenios)","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/abemaciclib-(Verzenios).pdf"},{"title":"Adriamcyine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-adriamycine.pdf"},{"title":"Behandeling Abemaciclib","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-abemaciclib.pdf"},{"title":"Bestraling (radiotherapie) bij borstkanker","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/bestraling-borstkanker.pdf"},{"title":"Borstafwijking: diagnose","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Borstafwijking-diagnose.pdf"},{"title":"Borstamputatie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Borstamputatie.pdf"},{"title":"Borstamputatie met okselklieruitruiming","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Borstamputatie-okselklieruitruiming.pdf"},{"title":"Borstamputatie met sentinelprocedure","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Borstamputatie-sentinelprocedure.pdf"},{"title":"Borstkanker. Hoe moet het nu verder","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Borstkanker-hoe-verder.pdf"},{"title":"Borstkliniek UZ Gent","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Borstkliniek.pdf"},{"title":"Borstsparende operatie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Borstsparende-operatie.pdf"},{"title":"Borstsparende operatie met okselklieruitruiming","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Borstsparende-operatie-okselklieruitruiming.pdf"},{"title":"Borstsparende operatie met sentinelonderzoek","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Borstsparende-operatie-sentinelonderzoek.pdf"},{"title":"Caelyx","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-caelyx.pdf"},{"title":"Carboplatine en Paclitaxel","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/carboplatine-paclitaxel.pdf"},{"title":"Carboplatinum - Caelyx","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-carboplatinum-caelyx.pdf"},{"title":"Carboplatinum - Gemzar","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-carboplatinum-gemzar.pdf"},{"title":"Ductaal carcinoma in situ","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Ductaal-carcinoma-in-situ.pdf"},{"title":"EC-schema","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-ec-schema.pdf"},{"title":"EC-schema bij gemetastaseerd borstcarcinoom","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-ec-schema-borstcarcinoom.pdf"},{"title":"Epirubicine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-epirubicine.pdf"},{"title":"Eribuline","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-eribuline.pdf"},{"title":"Ibrance","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Ibrance.pdf"},{"title":"Kadcyla","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-kadcyla.pdf"},{"title":"Mijn pathologieverslag begrijpen","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Pathologieverslag-begrijpen.pdf"},{"title":"Navelbine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Navelbine.pdf"},{"title":"Okselklieruitruiming","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/okselklieruitruiming.pdf"},{"title":"Paclitaxel","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/paclitaxel.pdf"},{"title":"Paclitaxel + Gemcitobine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/paclitaxel-gemcitobine.pdf"},{"title":"Paclitaxel in combinatie met Trastuzumab en Pertuzumab","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/paclitaxel-combinatie-trastuzumab-pertuzumab.pdf"},{"title":"Paclitaxel na EC-schema","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/paclitaxel-na-EC-schema.pdf"},{"title":"Perjeta","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Perjeta.pdf"},{"title":"Taxotere","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Taxotere.pdf"},{"title":"Taxotere - Cyclofosfamide","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Taxotere-Cyclofosfamide.pdf"},{"title":"Trastuzumab","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/trastuzumab.pdf"},{"title":"Trastuzumab - Deruxtecan (Enherty)","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/trastuzumab-deruxtecan (Enhertu).pdf"},{"title":"Triple-M","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Triple-M.pdf"},{"title":"Uitwendige borstprothese. Praktische adviezen","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Borstprothese-praktische-adviezen.pdf"},{"title":"Verpleegkundig spreekuur: uitgezaaide borstkanker","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/verpleegkundig spreekuur-uitgezaaide borstkanker.pdf"},{"title":"Waarom chemotherapie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/waarom-chemotherapie.pdf"},{"title":"Xeloda","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Xeloda.pdf"},{"title":"Zometa","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/zometa-aanvullende-behandeling.pdf"}],"count":42,"parent":"c0454f63-cdaf-4f86-a557-d7619410fd80"},{"id":"af2cdcf7-cd71-46cd-8833-2d0720671e40","name":"Chemotherapie","categories":[],"infosheets":[{"title":"ABVD","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-abvd.pdf"},{"title":"Adriamcyine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-adriamycine.pdf"},{"title":"Adriamycine - Ifosfamide","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-adriamycine-ifosfamide.pdf"},{"title":"BEACOPP escalated","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-beacopp-escalated.pdf"},{"title":"Caelyx","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-caelyx.pdf"},{"title":"Carboplatinum - Caelyx","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-carboplatinum-caelyx.pdf"},{"title":"Carboplatinum - Gemzar","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-carboplatinum-gemzar.pdf"},{"title":"CHOEP","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-choep.pdf"},{"title":"CHOP","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-chop.pdf"},{"title":"Cisplatinum + 5FU (4 dagen) + Cetuximab","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-cisplatinum-5fu-cetuximab.pdf"},{"title":"Cisplatinum-Adriamycine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-cisplatinum-adriamycine.pdf"},{"title":"Cytarabine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Cytarabine-subcutaan.pdf"},{"title":"DTIC","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-dtic.pdf"},{"title":"EC-schema","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-ec-schema.pdf"},{"title":"EC-schema bij gemetastaseerd borstcarcinoom","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-ec-schema-borstcarcinoom.pdf"},{"title":"Elastomeerpomp. Handleiding voor patiënt en thuisverpleegkundige","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Elastomeerpomp.pdf"},{"title":"Epirubicine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-epirubicine.pdf"},{"title":"Eribuline","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-eribuline.pdf"},{"title":"Gazyvaro - Bendamustine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-gazyvaro-bendamustine.pdf"},{"title":"Gazyvaro - Leukeran","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-gazyvaro-leukeran.pdf"},{"title":"Gemcitabine - Cisplatine - Dexamethasone","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-gemcitabine-cisplatine-dexamethasone.pdf"},{"title":"Ifosfamide mono","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-ifosfamide-mono.pdf"},{"title":"Kadcyla","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-kadcyla.pdf"},{"title":"Mabthera ACVBP","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-mabthera-acvbp.pdf"},{"title":"Mabthera Bendamustine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-mabthera-bendamustine.pdf"},{"title":"Voorzorgsmaatregelen bij chemotherapie d.m.v. tabletten","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/voorzorgsmaatregelen-chemotherapie-tabletten.pdf"},{"title":"Voorzorgsmaatregelen tijdens de chemotherapie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/voorzorgsmaatregelen-chemotherapie.pdf"}],"count":27,"parent":"c0454f63-cdaf-4f86-a557-d7619410fd80"},{"id":"dd7f5b3d-984b-4715-8163-dd8faa198abe","name":"Digestieve oncologie","categories":[],"infosheets":[{"title":"5 fluoro-uracil (5FU) en radiotherapie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/5-fluo-uracil(5-FU)-radiotherapie.pdf"},{"title":"Alvleesklier of pancreas","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/alvleesklier-pancreas.pdf"},{"title":"Angiogeneseremmers","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/angiogeneseremmers.pdf"},{"title":"Anti-emetica","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/anti-emetica.pdf"},{"title":"Capecitabine ((Xeloda®) en oxaliplatine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/capecitabine-(xeloda)-oxaliplatine.pdf"},{"title":"Capecitabine (Xeloda®)","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/capecitabine-(xeloda).pdf"},{"title":"Carboplatine - paclitaxel en radiotherapie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/carboplatine-paclitaxel-radiotherapie.pdf"},{"title":"Chirurgie bij slokdarmkanker","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/chirurgie-slokdarmkanker.pdf"},{"title":"Cisplatinum - Modified de Gramont","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/cisplatinum-modified de gramont.pdf"},{"title":"Cisplatinum 5FU en radiotherapie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/cisplatinum-5FU-radiotherapie.pdf"},{"title":"De dikke darm","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/de-dikke-darm.pdf"},{"title":"EGFR inhibitor","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/egfr-inhibitor.pdf"},{"title":"Flot","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/flot.pdf"},{"title":"Folfiri","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/folfiri.pdf"},{"title":"Folfox","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/folfox.pdf"},{"title":"Lonsurf","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Lonsurf.pdf"},{"title":"Modified de Gramont","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/modified-de-gramont.pdf"},{"title":"Ontslagbrochure Digestieve oncologie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/ontslagbrochure-digestieve-oncologie.pdf"},{"title":"Oxaliplatine (Eloxatin®) - 5FU en radiotherapie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/oxaliplatine-(eloxatin)-5-Fluorouracil (5FU)-radiotherapie.pdf"},{"title":"Pancreaschirurgie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/pancreaschirurgie.pdf"},{"title":"Schema Xeloda","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/xeloda.pdf"},{"title":"Stivarga","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Stivarga.pdf"},{"title":"TCF","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/tcf.pdf"},{"title":"Trastuzumab - Cisplatinum - 5FU","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/trastuzumab-cisplatinum 5-FU.pdf"},{"title":"Trastuzumab - Cisplatinum - Capecitabine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/trastuzumab-cisplatinum-capecitabine.pdf"}],"count":25,"parent":"c0454f63-cdaf-4f86-a557-d7619410fd80"},{"id":"7a727b79-86cb-4bcc-836c-b56cc005ed6a","name":"Gynaecologische oncologie","categories":[],"infosheets":[{"title":"Caelyx - Yondelis","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Caelyx-Yondelis.pdf"},{"title":"Carboplantinum - Mono","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Carboplatinum-Mono.pdf"},{"title":"Carboplatinum - Caelyx","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-carboplatinum-caelyx.pdf"},{"title":"Carboplatinum - Gemzar","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-carboplatinum-gemzar.pdf"},{"title":"Paclitaxel + Gemcitobine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/paclitaxel-gemcitobine.pdf"},{"title":"Team Pelviene oncologie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/team-pelviene-oncologie.pdf"}],"count":6,"parent":"c0454f63-cdaf-4f86-a557-d7619410fd80"},{"id":"0e2533ed-7b24-47ed-822d-1f69312717e0","name":"Hemato-oncologie en stamceltransplantatie","categories":[],"infosheets":[{"title":"ABVD","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-abvd.pdf"},{"title":"Allogene stamceltransplantatie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Allogene-stamceltransplantatie.pdf"},{"title":"AML behandeling: inductie + consolidatietherapie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/AML behandeling-inductie-consolidatietherapie.pdf"},{"title":"Aplastische anemie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Aplastische-anemie.pdf"},{"title":"Autologe stamceltransplantatie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Autologe-stamceltransplantatie.pdf"},{"title":"BEACOPP escalated","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-beacopp-escalated.pdf"},{"title":"Behandeling met revlimid","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/revlimid.pdf"},{"title":"Carfilzomib-Dexamethasone","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Carfilzomib-Dexamethasone.pdf"},{"title":"Carfilzomib-Revlimid-Dexamethasone","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Carfilzomib-Revlimid-Dexamethasone.pdf"},{"title":"Cellcept","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Cellcept.pdf"},{"title":"Centraal veneuze katheter","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Centraal-veneuze-katheter.pdf"},{"title":"CHOEP","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-choep.pdf"},{"title":"CHOP","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-chop.pdf"},{"title":"Citarabine SC","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/citarabine SC.pdf"},{"title":"Conditionering Melfalan","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/conditionering-Melfalan.pdf"},{"title":"Conditionering met cyclofosfamide en totale lichaamsbestraling","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Cyclofosfamide- totale-lichaamsbestraling.pdf"},{"title":"Conditionering met fludarabine, busulfan en ATG","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/conditionering-fludarabine-busulfan-ATG.pdf"},{"title":"Daratumumab","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Daratumumab.pdf"},{"title":"Gazyvaro - Bendamustine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-gazyvaro-bendamustine.pdf"},{"title":"Gazyvaro - Leukeran","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-gazyvaro-leukeran.pdf"},{"title":"Gemcitabine - Cisplatine - Dexamethasone","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-gemcitabine-cisplatine-dexamethasone.pdf"},{"title":"Glivec","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-glivec.pdf"},{"title":"Iclusig","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Iclusig.pdf"},{"title":"Ik, familiale donor?","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/ik-familiale-donor.pdf"},{"title":"Immuunsuppressiva","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Immuunsuppressiva.pdf"},{"title":"Imnovid","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Imnovid.pdf"},{"title":"Infecties voorkomen","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Infecties-voorkomen.pdf"},{"title":"Kiemarme voeding na stamceltransplantatie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/kiemarme-voeding-stamceltransplantatie.pdf"},{"title":"Lotgenotencontact en patiënteninformatie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/lotgenotencontact.pdf"},{"title":"Mabthera - CVP","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-mabthera-CVP.pdf"},{"title":"Mabthera - Fudarabine - Cyclofosfamide","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Mabthera-Fludarabine-Cyclofosfamide.pdf"},{"title":"Mabthera ACVBP","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-mabthera-acvbp.pdf"},{"title":"Mabthera Bendamustine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-mabthera-bendamustine.pdf"},{"title":"Mabthera CHOP","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Behandeling-Mabthera-CHOP.pdf"},{"title":"Matrix (schema)","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Matrix-schema.pdf"},{"title":"Melfalan - Prednisolone - Velcade","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Melfalan-Prednisolone-Velcade.pdf"},{"title":"Neoral-Sandimmun","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Neoral-Sandimmun.pdf"},{"title":"Nivolumab","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Behandeling-Nivolumab.pdf"},{"title":"Non-hodgkin-lymfoom","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/non-hodgkin-lymfoom.pdf"},{"title":"Prograft","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Prograft.pdf"},{"title":"Rapamune","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Rapamune.pdf"},{"title":"Rituximab","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Rituximab.pdf"},{"title":"Rituximab - Cyclofosfamide - Dexamethasone","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Rituximab-Cyclofosfamide-Dexamethasone.pdf"},{"title":"Rituximab - DHAP","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Rituximab-DHAP.pdf"},{"title":"Rituximab - Gemcitabine - Cisplatine - Dexamethasone","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Rituximab-Gemcitabine-Cisplatine-Dexamethasone.pdf"},{"title":"Sprycel","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Sprycel.pdf"},{"title":"Stamcollecte-aferese","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Stamcollecte-aferese.pdf"},{"title":"Thalidomide","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Thalidomide.pdf"},{"title":"Uw zorgverleners","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/uw-zorgverleners.pdf"},{"title":"Vaccinaties","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/vaccinaties.pdf"},{"title":"Velcade-Cyclofosfamide-Dexamethasone","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Velcade-Cyclofosfamide-Dexamethasone.pdf"},{"title":"Velcade-Dexamethasone","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Velcade-Dexamethasone.pdf"},{"title":"Velcade-Thalidomide-Dexamethasone","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Velcade-Thalidomide-Dexamethasone.pdf"},{"title":"Voedingsadviezen voor patiënten met een groot infectierisico","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Voedingsadviezen-patiënten-groot-infectierisico.pdf"},{"title":"Voorzorgsmaatregelen tijdens chemotherapie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Voorzorgsmaatregelen-tijdens-chemotherapie.pdf"},{"title":"Wanneer uw behandelende arts contacteren","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Wanneer-arts-contacteren.pdf"},{"title":"Welkom op de afdeling Hematologie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Welkom-afdeling-hematologie.pdf"},{"title":"Ziekte van Hodgkin","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/ziekte-Hodgkin.pdf"},{"title":"Ziekte van Kahler","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/ziekte-van-Kahler.pdf"}],"count":59,"parent":"c0454f63-cdaf-4f86-a557-d7619410fd80"},{"id":"c342e5d3-d6b8-4900-ae88-9f809d91495e","name":"Hoofd- en halstumoren","categories":[],"infosheets":[{"title":"Cemiplimab","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-cemiplimab.pdf"},{"title":"Cetuximab","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-cetuximab.pdf"},{"title":"Cisplatinum + 5FU (4 dagen) + Cetuximab","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-cisplatinum-5fu-cetuximab.pdf"},{"title":"Cisplatinum in combinatie met radiotherapie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-cisplatinum-radiotherapie.pdf"},{"title":"Voedingsproblemen bij hoofd- en halskanker","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/chemotherapie-bij-hoofd-en-halskanker.pdf"}],"count":5,"parent":"c0454f63-cdaf-4f86-a557-d7619410fd80"},{"id":"463d1a2d-aac5-4b21-8a51-6a809b876604","name":"Huidkanker","categories":[],"infosheets":[{"title":"Bredere resectie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Resectie.pdf"},{"title":"Bredere resectie en sentinelklierprocedure","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Resectie-sentinelklierprocedure.pdf"},{"title":"Dabrafenib-Tafinlar","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-dabrafenib-tafinlar.pdf"},{"title":"Dabrafenib-Tafinlar en Trametinib-Mekinist","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-dabrafenib-tafinlar-trametinib-mekinist.pdf"},{"title":"Diagnostische excisie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Diagnostische-excisie.pdf"},{"title":"DTIC","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-dtic.pdf"},{"title":"Een melanoom","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/een-melanoom.pdf"},{"title":"Imatinib","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/imatinib.pdf"},{"title":"Ipilimumab","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Behandeling-Ipilimumab.pdf"},{"title":"Ipilimumab en Nivolumab","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Behandeling-Ipilimumab-Nivolumab.pdf"},{"title":"Lymfeklieruitruiming of lymfadenectomie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Lymfeklieruitruiming-lymfadenectomie.pdf"},{"title":"Nivolumab","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Behandeling-Nivolumab.pdf"},{"title":"Pembrolizumab","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Behandeling-Pembrolizumab.pdf"},{"title":"Preventie zon en kanker","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Preventie-zon-kanker.pdf"},{"title":"Uw zorgverleners","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Uw-zorgverleners-dermato.pdf"},{"title":"Uw zorgverleners - Medische oncologie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Uw-zorgverleners-med-onco.pdf"},{"title":"Vemurafenib-Zelboraf","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Behandeling-Vemurafenib-Zelboraf.pdf"},{"title":"Zon en huidkanker","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/zon-en-huidkanker.pdf"}],"count":18,"parent":"c0454f63-cdaf-4f86-a557-d7619410fd80"},{"id":"c4a8259c-c3a8-437c-97f8-fe6c6456f871","name":"Neuro-oncologie","categories":[],"infosheets":[{"title":"Behandeling met Temodal","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Temodal.pdf"},{"title":"Behandeling Temodal in combinatie met radiotherapie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Temodal-radiotherapie.pdf"},{"title":"Lomustin-procarbozine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-lomustine-procarbazine.pdf"},{"title":"Uw zorgverleners","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/zorgverleners.pdf"}],"count":4,"parent":"c0454f63-cdaf-4f86-a557-d7619410fd80"},{"id":"e61d0ace-2c6b-4164-bf17-2cdb8b90be38","name":"Ondersteuning, welzijn en revalidatie","categories":[],"infosheets":[{"title":"EU'REKA'. Een revalidatieprogramma voor mensen na kanker","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/eureka.pdf"},{"title":"Mindfulness en kanker","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/mindfulness-kanker.pdf"},{"title":"Psychologische ondersteuning bij kanker","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/psychologische-ondersteuning-bij-kanker.pdf"},{"title":"Zorgpad prostaat team Eureka","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Zorgpad-prostaat.pdf"}],"count":4,"parent":"c0454f63-cdaf-4f86-a557-d7619410fd80"},{"id":"f00ba738-ae94-409e-9d0e-5143a789bf26","name":"Pelviene oncologie","categories":[],"infosheets":[{"title":"Caelyx - Yondelis","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Caelyx-Yondelis.pdf"},{"title":"Carboplantinum - Mono","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-Carboplatinum-Mono.pdf"},{"title":"Carboplatine en Paclitaxel","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/carboplatine-paclitaxel.pdf"},{"title":"Carboplatinum - Caelyx","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-carboplatinum-caelyx.pdf"},{"title":"Carboplatinum - Gemzar","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-carboplatinum-gemzar.pdf"},{"title":"Cervixcarcinoom","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Baarmoederhalskanker.pdf"},{"title":"Debulking","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/debulking.pdf"},{"title":"Endometriumcarcinoom","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Kanker-baarmoeder.pdf"},{"title":"Ovariumcarcinoom","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Kanker-eierstokken.pdf"},{"title":"Radiotherapie via intensiteitsgemoduleerde boogtherapie in combinatie met chemotherapie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Radiotherapie-intensiteitsgemoduleerde-boogtherapie -chemotherapie.pdf"},{"title":"Radiotherapie volgens boogtherapie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Radiotherapie-boogtherapie.pdf"},{"title":"Team Pelviene oncologie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/team-pelviene-oncologie.pdf"},{"title":"Verpleegkundig spreekuur","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/verpleegkundig-spreekuur.pdf"},{"title":"Vulvacarcinoom","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Kanker-schaamlippen.pdf"},{"title":"Vulvectomie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Vulvectomie.pdf"},{"title":"Wertheim","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Wertheim.pdf"}],"count":16,"parent":"c0454f63-cdaf-4f86-a557-d7619410fd80"},{"id":"77607faa-25d2-4235-a10e-048251731173","name":"Preventie","categories":[],"infosheets":[{"title":"Preventie zon en kanker","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Preventie-zon-kanker.pdf"}],"count":1,"parent":"c0454f63-cdaf-4f86-a557-d7619410fd80"},{"id":"84b9b0ff-39ed-4081-8c5a-2254949542d2","name":"Sarcomen en bottumoren","categories":[],"infosheets":[{"title":"Adriamycine - Ifosfamide","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-adriamycine-ifosfamide.pdf"},{"title":"Chondrosarcoom","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/chondrosarcoom.pdf"},{"title":"Cisplatinum-Adriamycine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-cisplatinum-adriamycine.pdf"},{"title":"Cisplatinum-doxorubicine-methotrexaat","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-cisplatinum-doxorubicine-methotrexaat.pdf"},{"title":"Ewingsarcoom","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/ewingsarcoom.pdf"},{"title":"Glivec","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-glivec.pdf"},{"title":"Ifosfamide mono","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-ifosfamide-mono.pdf"},{"title":"Ifosfamide-Etoposide","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-ifosfamide-etoposide.pdf"},{"title":"IVADO","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-IVADO.pdf"},{"title":"Nexavar","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Behandeling-Nexavar.pdf"},{"title":"Osteosarcoom","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/osteosarcoom.pdf"},{"title":"Pijnstilling na ingreep","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/pijnstilling-na-ingreep.pdf"},{"title":"Sutent","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Behandeling-Sutent.pdf"},{"title":"Uw zorgverleners","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Uw-zorgverleners-sarcomen.pdf"},{"title":"VAC","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Behandeling-VAC.pdf"},{"title":"VAI","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Behandeling-VAI.pdf"},{"title":"VDC-IE","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/behandeling-VDC-IE.pdf"},{"title":"VIDE","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Behandeling-VIDE.pdf"},{"title":"Votrient","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/votrient.pdf"},{"title":"Wat is een biopsie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Wat-is-een-biopsie.pdf"},{"title":"Wekedelensarcoom","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/wekedelensarcoom.pdf"},{"title":"Yondelis","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Behandeling-Yondelis.pdf"}],"count":22,"parent":"c0454f63-cdaf-4f86-a557-d7619410fd80"},{"id":"24b918ae-7213-46f7-aa7b-44361856c81f","name":"Thoracale oncologie","categories":[],"infosheets":[{"title":"Afatinib (Giotrif®)","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/afatinib.pdf"},{"title":"Alectinib (Alecensa®)","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/alectinib.pdf"},{"title":"Ceritinib (Zykadia®) ","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Ceritinib.pdf"},{"title":"Crizotinib (Xalkori®)","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/crizotinib.pdf"},{"title":"Erlotinib ","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/erlotinib.pdf"},{"title":"Gefitinib (Iressa®) ","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/gefitinib.pdf"},{"title":"Lorlatinib","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/lorlatinib.pdf"},{"title":"Nintedanib (Vargatef®)","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Nintedanib.pdf"},{"title":"Osimertinib (Tagrisso®)","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/osimertinib.pdf"}],"count":9,"parent":"c0454f63-cdaf-4f86-a557-d7619410fd80"},{"id":"12b1be87-7ab6-44f7-aa34-bfe0602644fb","name":"Urologische oncologie","categories":[],"infosheets":[{"title":"Chemo-behandeling-BEP-schema","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Chemo-behandeling-met-BEP-schema.pdf"},{"title":"Chemo-behandeling-VIP-schema","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Chemo-behandeling-met-VIP-schema.pdf"},{"title":"Cisplatinum - Gemcitabine","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Behandeling-Cisplatinum-gemcitabine.pdf"},{"title":"Leven met een urostoma","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/leven-met-urostoma.pdf"},{"title":"Multidisciplinair spreekuur nierkanker","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/multidisciplinair-spreekuur-nierkanker.pdf"},{"title":"MVAC (dose dense)","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Behandeling-MVAC-dose-dense.pdf"},{"title":"Pembrolizumab","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Behandeling-Pembrolizumab.pdf"},{"title":"Robotgeassisteerde cystectomie met neoblaas man","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/robotgeassisteerde-cystectomie-met-neoblaas-(man).pdf"},{"title":"Robotgeassisteerde cystectomie met neoblaas vrouw","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/robotgeassisteerde-cystectomie-met-neoblaas-(vrouw).pdf"},{"title":"Robotgeassisteerde cystectomie met urostoma man","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/robotgeassisteerde-cystectomie-met-urostoma-(man).pdf"},{"title":"Robotgeassisteerde cystectomie met urostoma vrouw","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/robotgeassisteerde-cystectomie-met-urostoma-(vrouw).pdf"},{"title":"Xtandi","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/enzalutamide.pdf"},{"title":"Zytiga","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/abiraterone.pdf"}],"count":13,"parent":"c0454f63-cdaf-4f86-a557-d7619410fd80"},{"id":"1cdc7674-f401-4eb8-82c5-1d4fe2c16c64","name":"Voeding","categories":[],"infosheets":[{"title":"Adviezen bij misselijkheid en braken","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/adviezen-misselijkheid-braken.pdf"},{"title":"Adviezen voor eiwit- en energieverrijkte voeding bij diabetes","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Adviezen-eiwit-en-energieverrijkte-voeding.pdf"},{"title":"Conseils alimentaires après oesophagectomie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/conseils-alimentaires-oesophagectomie.pdf"},{"title":"Dagschema energierijke voeding","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/dagschema-energierijke-voeding.pdf"},{"title":"Dagschema na maagresectie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/dagschema-maagresectie.pdf"},{"title":"Dagschema na slokdarmresectie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/dagschema-slokdarmresectie.pdf"},{"title":"Dieetadviezen bij colostoma","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Voedingsadviezen-colostoma.pdf"},{"title":"Dieetconsultatie oncologie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/dieetconsultatie-oncologie.pdf"},{"title":"Droge mond als gevolg van een kankerbehandeling","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/droge-mond-bij-kankerbehandeling.pdf"},{"title":"Eet- en leefstijladviezen bij zuurbranden","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Eet-leefstijladviezen-zuurbranden.pdf"},{"title":"Gebruik van bijvoeding","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Gebruik-bijvoeding.pdf"},{"title":"Kiemarme recepten","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/kiemarme-recepten.pdf"},{"title":"Kookboekje voor mensen met slikproblemen","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/kookboek-slikproblemen.pdf"},{"title":"Resource complete (Nestlé)","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Resource-complete-Nestle.pdf"},{"title":"Schéma nutritionnele après oesophagectomie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Schéma-oesophagectomie.pdf"},{"title":"Schéma nutritionnele après résection gastrique","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Schéma-résection-gastrique.pdf"},{"title":"Slechte eetlust - calorierijke voeding","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Slechte-eetlust.pdf"},{"title":"Tips bij constipatie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Tips-constipatie.pdf"},{"title":"Tips bij diarree","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Tips-diarree.pdf"},{"title":"Tips bij diverticulitis","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Tips-diverticulitis.pdf"},{"title":"Tips bij high output stoma","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Tips-high-output-stoma.pdf"},{"title":"Tips bij LAR-syndroom","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Tips-LAR.pdf"},{"title":"Verminderde eetlust en smaakverandering","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/verminderde-eetlust- smaakverandering.pdf"},{"title":"Vetarme voeding met MCT - VET","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/vetarme voeding.pdf"},{"title":"Voeding na Whipple-operatie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Voeding-na-whipple-operatie.pdf"},{"title":"Voeding tijdens en na de behandeling van borstkanker","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/voeding-tijdens-na-borstkanker.pdf"},{"title":"Voedingsadvies bij kauw-of slikklachten","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Voedingsadvies-kauw-of-slikklachten.pdf"},{"title":"Voedingsadviezen bij gehele of gedeeltelijke maagresectie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Voedingsadviezen-maagresectie.pdf"},{"title":"Voedingsadviezen bij ileostoma","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Voedingsadviezen-ileostoma.pdf"},{"title":"Voedingsadviezen bij orale mucositis","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/voedingsadviezen-orale-mucositis.pdf"},{"title":"Voedingsadviezen bij slokdarmresectie","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Voedingsadviezen-slokdarmresectie.pdf"},{"title":"Voedingsadviezen bij subobstructief beeld","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/voedingsadviezen-subobstructief-beeld.pdf"}],"count":32,"parent":"c0454f63-cdaf-4f86-a557-d7619410fd80"},{"id":"6da1fd83-1173-4ae7-b6bf-75296bce6a82","name":"Vruchtbaarheid","categories":[],"infosheets":[{"title":"Effect van oncologische therapie op de mannelijke vruchtbaarheid","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Effect-oncologische-therapie-mannelijke-vruchtbaarheid.pdf"},{"title":"Effect van oncologische therapie op de vrouwelijke vruchtbaarheid","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Effect-oncologische-therapie-vrouwelijke-vruchtbaarheid.pdf"},{"title":"Invriezen en onderzoek van testiculair weefsel bij prepubertaire jongens","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Invriezen-testiculair-weefsel-prepubertaire-jongens.pdf"},{"title":"Vruchtbaarheid bij vrouwelijke patiënten met kanker","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/vruchtbaarheid-vrouwelijke-patienten.pdf"},{"title":"Zaadcellen invriezen bij pubertaire jongens en adolescenten","path":"http://www.uzgent.be/nl/home/Lists/PDFs patienteninformatiefolders/Invriezen-zaadcellen-pubertaire-jongens-adolescenten.pdf"}],"count":5,"parent":"c0454f63-cdaf-4f86-a557-d7619410fd80"}],"infosheets":null,"count":307}]}